CD34 and leukemia: A retrospective study involving 34 adult leukaemia patients (AML and ALL) who received TCR-αβ-depleted haploidentical HSCT with CD34+ progenitors after a myeloablative conditioning regimen showed favourable GVHD-free survival rates [23].